• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Psychiatry

Free alternatives comparable to Mini-Mental State Examination

byAshley AaroeandJames Jiang
June 10, 2015
in Psychiatry
Reading Time: 3 mins read
Free alternatives comparable to Mini-Mental State Examination
Share on FacebookShare on TwitterShare on LinkedIn

1. In this systematic review and meta-analysis, out of 10 alternative screening tests, the best freely available alternatives to the Mini-Mental State Examination in screening for dementia were the Mini-Cog and Addenbrooke’s Cognitive Examination (ACE-R) tests.

2. Moreover, it was found that the best freely available alternative to the Mini-Mental State Examination in screening for mild cognitive impairment (MCI) was the Montreal Cognitive Assessment (MOCA).

Evidence Rating Level: 1 (Excellent)

Study Rundown: Dementia and cognitive impairment, while prevalent, are under-recognized in clinical practice. Complications of dementia can be better recognized in patients who are diagnosed early. Screening tools provide quick and useful means to assess mental status in patients both in office and in a hospital setting. One of the most commonly recognized screening tools for dementia is the Mini-Mental State Examination (MMSE), a proprietary screening test whose intellectual property rights are owned by Psychological Assessment Resources. Although it is the most commonly used tool, its proprietary nature limits its accessibility. This study sought to assess whether other dementia screening tests in the public domain may be viable alternatives.

This systematic review and meta-analysis found that 10 alternative tests performed similarly well in detection of dementia compared to the MMSE. In particular, the Mini-Cog test and Addenbrooke’s Cognitive Examination–Revised (ACE-R) had the best diagnostic performances in detection of dementia. The MOCA was found to be comparable to the MMSE in detection of mild cognitive impairment. Limitations of this study include that it did not allow for directly comparing the performance of various screening tests in the same populations. Moreover, articles included were limited to cross-sectional studies in English.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

An artificial intelligence model demonstrates the potential for improving the efficiency of structural heart disease screening using electrocardiograms

Relevant Reading: The Mini-Mental State Examination: A Comprehensive Review

In-Depth [systematic review and meta-analysis]: A list of alternative dementia screening tests was identified per previous work. Literature searches for these tests were performed in MEDLINE, EMBASE, and PsychINFO databases, and Google Scholar. Articles were limited to peer-reviewed cross-sectional studies in English. Screening tests were classified by administration time (<5 minutes, <10 minutes, <20 minutes). 26,165 abstracts were identified, and ultimately 149 studies published from 1989 to 2014 were included. 11 screening tests were examined, including the MMSE, Abbreviated Mental Test, Sunderland’s Clock Drawing test, Shulman’s Clock Drawing Test, GPCOG, IQCODE (both long and short forms), Mini-Cog, ACE-R, Memory Impairment Screen, Montreal Cognitive Assessment, modified MMSE, and verbal fluency tests.

Most tests had comparable performance to the MMSE. The Mini-Cog test and the ACE-R were the best alternatives to the MMSE. For the Mini-Cog test, the pooled sensitivity for all studies was 0.91 (95% CI, 0.80-0.96), and the pooled specificity was 0.86 (95% CI, 0.74-0.93). For the ACE-R test, the pooled sensitivity was 0.92 (95% CI, 0.90-0.94) and the pooled specificity was 0.89 (95% CI, 0.84-0.93). The Montreal Cognitive Assessment had comparable performance to the MMSE on detection of mild cognitive impairment with sensitivity and specificity of 0.89 and 0.75, respectively.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: dementiascreening
Previous Post

Applicants given extra time on MCAT have lower USMLE pass rates

Next Post

Incomplete HPV vaccine schedules may confer similar levels of protection

RelatedReports

A calendar, a specimen jar, and a brush are depicted alongside a microscopic view of cervical cells, indicating cervical cancer screening.
All Specialties

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

October 23, 2026
An illustration featuring a heart within a house, with a stethoscope, a scale, and medication, symbolizing heart failure home hospital care.
Artificial Intelligence

An artificial intelligence model demonstrates the potential for improving the efficiency of structural heart disease screening using electrocardiograms

October 21, 2026
A senior woman is depicted alongside images of a brain, a magnifying glass, a test tube, and playing cards, suggesting cognitive assessment related to dementia.
Chronic Disease

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

October 13, 2026
A graphic featuring a heart, kidney, bladder, stethoscope, and an ultrasound machine, arranged in a flower-like design on a light blue background.
Weekly Rewinds

2 Minute Medicine Rewind October 12, 2026

October 17, 2026
Next Post
Incomplete HPV vaccine schedules may confer similar levels of protection

Incomplete HPV vaccine schedules may confer similar levels of protection

Low rotavirus vaccination coverage associated with ongoing disease transmission

Rotavirus vaccine linked with decrease in acute gastroenteritis hospitalizations

Traumatic spinal cord injury rates remain stable in the United States

Traumatic spinal cord injury rates remain stable in the United States

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.